OrbiMed’s Braveheart Bio BRVE Stock Holding History
Bought
Maintained
Sold
Other funds holding BRVE
OrbiMed's BRVE Position: Q3 2026 in Review
OrbiMed opened a new position in Braveheart Bio (BRVE) in Q3 2026: 12,175,159 shares worth $246M. The stake represents 4.47% of the portfolio and ranks #5 among its holdings.
64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.
- OrbiMed held 12,175,159 shares of Braveheart Bio worth $246M as of Q3 2026.
- Braveheart Bio was a new OrbiMed position in Q3 2026.
- Braveheart Bio made up 4.47% of OrbiMed's portfolio in Q3 2026, its #5 holding.
- 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.